Development and Evaluation of Nutraceutical Tablets from Selected Plant Extracts: A Novel Approach to Functional Medicine
DOI:
https://doi.org/10.29070/n3eggx09Keywords:
Plant extracts, Prebiotic activity, Microbiological quality standards, Bioactive compounds, Nutraceutical tabletsAbstract
The potential of a seed powder blend made of Cucumis melo, Punica granatum, and Linum usitatissimum in a 1:1:1 ratio is investigated in this study. In order to guarantee a consistent particle size distribution (10–30 µm), the seeds were ground into a fine powder. The parameters of bulk powder showed strong cohesion and poor flow ability. Photo microscopy, however, showed fibrous, capsular structures that were perfect for formulation. Significant growth of Lactobacillus acidophilus and Bifidobacterium bifidum indicated that the mix had superior prebiotic potential compared to individual seed powders and the conventional chicory powder. It also showed remarkable antioxidant activity. Studies on animals verified the blend's effectiveness and safety. A 40-day feeding trial in Albino Wistar rats demonstrated its haematinic effects, raising haemoglobin levels from 12.1% to 16.5% and red blood cell counts from 7.46 to 9.55 million/mm³. Acute toxicity trials revealed no negative effects. Additionally, the combination decreased VLDL and triglycerides and raised serum protein levels, suggesting possible cardiovascular advantages. Its safety for those with diabetes is supported by the fact that blood glucose levels stayed within the usual range.
The product, which was made as capsules, complied with pharmacopoeial requirements for disintegration time and weight variation. A shelf life of nine to twelve months is suggested by stability studies conducted under accelerated settings. Over the course of three months, the blend's prebiotic activity stayed steady, maintaining its capacity to promote probiotic growth. This nutraceutical formulation is a good option for treating anemia, malnutrition, and metabolic disorders since it provides a promising blend of antioxidant, prebiotic, and health-promoting qualities.
References
Abdul MIM, Siddique S, Rahman SAU, Lateef D, Dan S, Mandal P, Bose A (2018) A critical insight of modern herbal drugs therapy under the purview of toxicity and authenticity. Biomed Res 29(16):3255–3260
De B, Singla KR, Bhandari K, Katakam P, Adiki KS, Mitra A (2017) Study the enzyme inhibitory potentialities of a phytocomposite for Type 2 diabetes by in silico GRIP docking. IJOPILS 5(3):34–57
Djordjevic SM. From medicinal plants raw material to herbal remedies. Intech Open Science 2017;269–88
Ekor M. The growing use of herbal medicines: Issue relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014;4:177
Kambizi LGBM, Goosen BM, Taylor MB, Afolayan AJ (2007) Anti-viral effects of aqueous extracts of Aloe ferox and Withania somnifera on herpes simplex virus type 1 in cell culture: research in action. S Afr J Sci 103(9):359–360
Katiyar CK, Duggal RK and Rao BVJ, Dabur Research Foundation (2002) Herbal composition and method of manufacturing such composition for the management of gynecological disorders. U.S. Patent 6,455,077
Kayani S, Ahmad M, Zafar M, Sultana S, Khan MPZ, Ashraf MA, Hussain J, Yaseen G (2014) Ethnobotanical uses of medicinal plants for respiratory disorders among the inhabitants of Gallies–Abbottabad, Northern Pakistan. J Ethnopharmacol 156:47–60
Khanuja SPS, Chaturvedi P, Singh AK, Shasany AK, Agarwal VK, Gupta VK, Gupta SC, Tripathy AK, Pal A, Saikia D and Darokar MP (2007) Anti-dermatophytic preparation and use thereof. U.S. Patent 7,291,349
Khanuja SPS, Srivastava S, Shasney A K, Darokar MP, Kumar TRS, Agarwal KK, Ahmed A, Patra NK, Sinha P, Dhawan S, Saikia D and Kumar S (2003) US Patent No 6514541
Mahajon B, Chincholikar M, Narayanan R, Venigalla S, Sharma BS, Ahmad A. Basis for the use of substitutes for medicinal flora and harmonization of rational use: A critical appraisal based on “Kitab al-Abdal”: A classical compendium of unani medicine. J Drug Res Ayurvedic Sci 2020;5:121–31
Mallare JT, Karabell AH, Mieyer PV, Stender SRS, Christensen ML (2005) Current and future treatment of metabolic syndrome and type 2 diabetes in children and adolescents. Diabetes Spectr 18(4):220–228
Parasuraman S, Thing GS, Dhanaraj SA (2014) Polyherbal formulation: concept of ayurveda. Phcog Rev 8(16):73–80
Saklayen MG (2018) The Global epidemic of the metabolic syndrome. Curr Hypertens Rep 20(12):1–8
Sharma AK, Kumar R, Mishra A, Gupta R. Problems associated with clinical trials of Ayurvedic medicines. Rev Bras Farmacogn 2010;20:276–81
Van Zwieten PA, Visser FC (2006) Metabolic syndrome: pharmacological treatment. Heart Metab 30:15–20
This work is licensed under a 